• 76-year-old Don Wright Has New Goal After Completing 100 Marathons with Myeloma
  • FDA Will Review Amgen’s Request to Expand Use of Xgeva for Multiple Myeloma
  • FDA Approves Darzalex Combo Therapy for Previously Treated Multiple Myeloma Patients
  • Dragonfly Therapeutics and Celgene Partnering on Blood-Cancer Therapies
  • First Patient Dosed in Phase 3 BOSTON Trial Evaluating Selinexor for Multiple Myeloma
  • BMT Program at MedStar Georgetown Completes 100th Blood Stem Cell Transplant
  • Myeloma Patient Enrollment in 2 Keytruda Trials Suspended After Unexplained Deaths
  • Caris Collaboration to Identify Eligible Participants for NCI-MATCH Trial
  • CAR T-Cell Therapy Nearly Eliminates Tumors in All Relapsed or Refractory Myeloma Patients in Phase 1 Trial
  • New CAR T-cell Therapy Seen to Induce Lasting Remission in Advanced Multiple Myeloma Patients
  • Oncology Venture Enrolls First Multiple Myeloma Patient in Clinical Trial
  • Adding Darzalex to Standard Therapies in Multiple Myeloma Patients Continues to Show Improved Results